These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3907819)

  • 1. Studies on rat mammary adenocarcinomas: a model for metastasis.
    Ramshaw IA; Badenoch-Jones P
    Cancer Metastasis Rev; 1985; 4(3):195-208. PubMed ID: 3907819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous capillary tube migration of metastatic rat mammary adenocarcinoma cells.
    Badenoch-Jones P; Ramshaw IA
    Invasion Metastasis; 1984; 4(2):98-110. PubMed ID: 6539758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human choriogonadotropin-like material correlates with metastatic phenotype of R3230 AC rat adenocarcinoma.
    Acevedo HF; Kellen JA; Wong AC; Gardner HA; Szalai JP
    Cancer Invest; 1987; 5(3):177-85. PubMed ID: 3651864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced plasminogen activator production by highly metastatic variant cell lines of a rat mammary adenocarcinoma.
    Ramshaw IA; Badenoch-Jones P; Grant A; Maxted M; Claudianos C
    Invasion Metastasis; 1986; 6(3):133-44. PubMed ID: 3733365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of rat tumour cell hybrids: procoagulant and fibrinolytic activities.
    Badenoch-Jones P; Ramshaw IA
    Aust J Exp Biol Med Sci; 1985 Feb; 63 ( Pt 1)():91-8. PubMed ID: 4040360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma.
    Neri A; Welch D; Kawaguchi T; Nicolson GL
    J Natl Cancer Inst; 1982 Mar; 68(3):507-17. PubMed ID: 6950180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-chain, urokinase-type plasminogen activator in a tumor model linked to metastatic potential.
    Kellen JA; Mirakian A; Wong A
    In Vivo; 1988; 2(2):155-7. PubMed ID: 2979833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome and DNA analyses of rat 13762NF mammary adenocarcinoma cell lines and clones of different metastatic potentials.
    Pearce V; Pathak S; Mellard D; Welch DR; Nicolson GL
    Clin Exp Metastasis; 1984; 2(4):271-86. PubMed ID: 6543705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 6-thioguanine-resistant variant of the 13762 cell line which is no longer tumorigenic or metastatic.
    Ramshaw IA; Carlsen SA; Hoon D; Warrington RC
    Int J Cancer; 1982 Nov; 30(5):601-7. PubMed ID: 6891375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased metastatic ability and bone formation of a mammary adenocarcinoma in vivo after in vitro passaging.
    Hoon DB; Wang HC; Ramshaw IA
    Eur J Cancer Clin Oncol; 1984 Dec; 20(12):1517-26. PubMed ID: 6594243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of cell fusion to analyse factors involved in tumour cell metastasis.
    Ramshaw IA; Carlsen S; Wang HC; Badenoch-Jones P
    Int J Cancer; 1983 Oct; 32(4):471-8. PubMed ID: 6684641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of plasminogen activator production with tumor metastasis in a rat model.
    Carlsen SA; Ramshaw IA; Warrington RC
    Cancer Res; 1984 Jul; 44(7):3012-6. PubMed ID: 6539167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneously metastasizing variants derived from MNU-induced rat mammary tumour.
    Williams JC; Gusterson BA; Coombes RC
    Br J Cancer; 1982 Apr; 45(4):588-97. PubMed ID: 7073949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships of prostaglandin E and natural killer sensitivity to metastatic potential in murine mammary adenocarcinomas.
    Fulton AM; Heppner GH
    Cancer Res; 1985 Oct; 45(10):4779-84. PubMed ID: 4027966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive expression and secretion of proteases in non-metastatic SP1 mammary carcinoma cells and its metastatic sublines.
    Korczak B; Kerbel RS; Dennis J
    Int J Cancer; 1991 Jun; 48(4):557-61. PubMed ID: 2045200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activators as markers of tumor colonization potential.
    Ng R; Kellen JA; Wong AC
    Invasion Metastasis; 1983; 3(4):243-8. PubMed ID: 6689573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth of rat mammary adenocarcinoma cells in semisolid clonogenic medium not correlated with spontaneous metastatic behavior: heterogeneity in the metastatic, antigenic, enzymatic, and drug sensitivity properties of cells from different sized colonies.
    Nicolson GL; Lembo TM; Welch DR
    Cancer Res; 1988 Jan; 48(2):399-404. PubMed ID: 2825974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lectin-binding characteristics of related high- and low-metastatic rat mammary adenocarcinoma cell lines.
    Badenoch-Jones P; Claudianos C; Ramshaw IA
    Invasion Metastasis; 1987; 7(5):284-96. PubMed ID: 3679743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant myoepithelial cells are associated with the differentiated papillary structure and metastatic ability of a syngeneic murine mammary adenocarcinoma model.
    Bumaschny V; Urtreger A; Diament M; Krasnapolski M; Fiszman G; Klein S; Joffé EB
    Breast Cancer Res; 2004; 6(2):R116-29. PubMed ID: 14979922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between urokinase-type plasminogen activator production and the metastasizing ability of two murine mammary adenocarcinomas.
    Pereyra-Alfonso S; Haedo A; Bal de Kier Joffé E
    Int J Cancer; 1988 Jul; 42(1):59-63. PubMed ID: 3134309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.